Radionuclide therapy of HER2-expressing human xenografts using affibody-based peptide nucleic acid-mediated pretargeting: In vivo proof of principle
Kristina Westerlund, Mohamed Altai, Bogdan Mitran, Mark Konijnenberg, Maryam Oroujeni, Christina Atterby, Marion De Jong, Anna Orlova, Johanna Mattsson, Patrick Micke, Amelie Eriksson Karlströmy, Vladimir Tolmachevy
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Radionuclide therapy of HER2-expressing human xenografts using affibody-based peptide nucleic acid-mediated pretargeting: In vivo proof of principle'. Together they form a unique fingerprint.